There are still lots of open positions. Let's find the one that's right for you.
As the Associate Director, US HCP Marketing, you'll be a vital part of the commercial NF1 PN brand team, driving engagement strategies for healthcare professionals and patients. Your role will be pivotal in executing the brand strategy for Koselugo, a groundbreaking MEK 1/2 inhibitor approved by the FDA for treating plexiform neurofibromas associated with neurofibromatosis type 1 (NF1). Reporting to the Head of US Marketing, NF1 PN, you'll be at the forefront of commercialization efforts for this life-changing treatment.